Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;29(12):3580-3589.
doi: 10.1111/ene.15536. Epub 2022 Sep 11.

APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal-dominant Alzheimer's disease

Ove Almkvist  1   2 , Charlotte Johansson  2   3 , Jose Laffita-Mesa  3 , Steinunn Thordardottir  3 , Caroline Graff  2   3
Affiliations

APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal-dominant Alzheimer's disease

Ove Almkvist et al. Eur J Neurol. 2022 Dec.

Abstract

Background and purpose: The aim was to investigate the effect of APOE ε4 allele on cognitive decline in adAD. Presence of the APOE ε4 allele reduces age of symptom onset, increases disease progression, and lowers cognitive performance in sporadic Alzheimer's disease (AD), while the impact of the APOE ε4 allele in autosomal-dominant AD (adAD) is incompletely known.

Methods: Mutation carriers (MCs; n = 39) and non-carriers (NCs; n = 40) from six adAD families harbouring a mutation in the APP (28 MCs and 25 NCs) or the PSEN1 genes (11 MCs and 15 NCs) underwent repeated cognitive assessments. A timeline of disease course was defined as years to expected age of clinical onset (YECO) based on history of disease onset in each family. The MC and NC groups were comparable with regard to demographics and prevalence of the APOE ε4 allele. The relationship between cognitive decline and YECO, YECO2 , education, APOE, and APOE-by-YECO interaction was analysed using linear mixed-effects models.

Results: The trajectory of cognitive decline was significantly predicted by linear and quadratic YECO and education in MCs and was determined by age and education in NCs. Adding APOE ε4 allele (presence/absence) as a predictor did not change the results in the MC and NC groups. The outcome also remained the same for MCs and NCs after adding the APOE-by-YECO interaction as a predictor. Analyses of APP and PSEN1 MCs separately showed favourable APOE-by-YECO interaction in APP (less steep decline) and unfavourable interaction in PSEN1 (steeper decline), linked to the APOE ε4 allele.

Conclusion: The APOE ε4 allele influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with adAD, indicating a possible antagonistic pleiotropy.

Keywords: APOE; APP/PSEN1; autosomal-dominant Alzheimer's disease; cognition; longitudinal.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
Longitudinal cognitive decline across time of disease advancement (years to expected clinical onset [YECO]) on five tests in APP and PSEN1 mutation carriers (MCs) divided into APOE subgroups, showing APP MCs with and without the ε4 allele in the left column and PSEN1 MCs with and without the ε4 allele in the right column. RAVLT, Rey Auditory Verbal Learning Test; Sim, Similarities test; TMTA, Trailmaking Test A
See this image and copyright information in PMC

References

    1. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921‐923. - PubMed
    1. Sabbagh MN, Malek‐Ahmadi M, Dugger BN, et al. The influence of apolipoprotein E genotype on regional pathology in Alzheimer's disease. BMC Neurol. 2013;13:44. - PMC - PubMed
    1. Sudre CH, Cardoso MJ, Frost C, et al. APOE e4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis. Neurobiol Aging. 2017;53:67‐75. - PubMed
    1. Kerchner GA, Berdnik D, Shen JC, et al. APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory. Neurology. 2014;82:691‐697. - PMC - PubMed
    1. Kester MI, Blankenstein MA, Bouwman FH, van Elk EJ, Scheltens P, van der Flier WM. CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age. J Alzheimers Dis. 2009;16:601‐607. - PubMed

Publication types